How does methotrexate toxicity typically show up?
Methotrexate toxicity often stems from high doses, impaired kidney function, or drug interactions, leading to symptoms across multiple systems. Common signs include severe nausea, vomiting, and diarrhea, which can start within hours of exposure. Fatigue and mouth sores (stomatitis) are frequent early indicators, while bone marrow suppression causes low blood cell counts, resulting in easy bruising, bleeding, infections, or fever.[1][2]
What gastrointestinal and skin symptoms should patients watch for?
GI effects dominate, with persistent vomiting, abdominal pain, and bloody diarrhea signaling acute toxicity. Skin reactions include rash, redness, and painful ulcers in the mouth or digestive tract. These can escalate quickly in high-dose regimens used for cancer.[1][3]
Which lab abnormalities confirm toxicity?
Blood tests reveal key markers: elevated liver enzymes (ALT/AST), high creatinine from kidney damage, and pancytopenia (low white cells, red cells, platelets). Serum methotrexate levels above 10 micromolar beyond 48 hours post-dose indicate severe risk.2
How does toxicity differ in low-dose versus high-dose use?
In rheumatoid arthritis patients on low weekly doses, toxicity mimics flu-like symptoms with milder GI upset and hepatotoxicity. High-dose chemotherapy versions (e.g., for leukemia) trigger life-threatening mucositis, myelosuppression, and acute kidney injury, often requiring leucovorin rescue.[1][3]
What are the most serious long-term risks?
Chronic exposure risks liver fibrosis or cirrhosis, lung inflammation (pneumonitis), and neurological issues like confusion or seizures in severe cases. Renal failure can compound problems, making monitoring critical.2
When does toxicity usually occur and how is it treated?
Symptoms peak 24-72 hours after dosing. Treatment involves stopping the drug, hydration, leucovorin (folinic acid) to bypass folate blockade, and glucarpidase for very high levels. Dialysis helps in kidney failure.[1][3]
[1]: https://www.ncbi.nlm.nih.gov/books/NBK556114/
[2]: https://www.uptodate.com/contents/methotrexate-drug-information
[3]: https://www.cancer.gov/about-cancer/treatment/drugs/methotrexate